The Expanding Role of Tumor Necrosis Factor- Inhibitors in the Management of Rheumatic Diseases

ISSN： 1567-2034

Source： Medicinal Chemistry Reviews - Online, Vol.1, Iss.4, 2004-10, pp. : 479-491

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tumor Necrosis Factor Inhibitors as Therapeutic Choice in Psoriasis

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 8, Iss. 1, 2009-03 ,pp. : 47-50

Bentham Science Publishers

Access to resources Recommend Favorite

Tumor Necrosis Factor Inhibitors in the Management of Juvenile Idiopathic Arthritis: An Evidence-Based Review

By Shenoi Susan Wallace Carol A.

Pediatric Drugs, Vol. 12, Iss. 6, 2010-12 ,pp. : 367-377

Adis International

Access to resources Recommend Favorite

The Role of Melatonin in Rheumatic Diseases

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 9, Iss. 4, 2009-08 ,pp. : 453-456

Bentham Science Publishers

Access to resources Recommend Favorite

The Effects of Tumor Necrosis Factor Inhibitors on Cardiovascular Risk in Rheumatoid Arthritis

Current Pharmaceutical Design, Vol. 18, Iss. 11, 2012-04 ,pp. : 1502-1511

Bentham Science Publishers

Access to resources Recommend Favorite

Tumor Necrosis Factor Blocking Therapy and Congestive Heart Failure in Patients with Inflammatory Rheumatic Disorders: A Systematic Review

Current Medicinal Chemistry, Vol. 22, Iss. 16, 2015-05 ,pp. : 1892-1902

Bentham Science Publishers

Access to resources Recommend Favorite